Tags

Type your tag names separated by a space and hit enter

Markers of hypercoagulability and inflammation predict mortality in patients with heart failure.
J Thromb Haemost. 2006 May; 4(5):1017-22.JT

Abstract

BACKGROUND AND AIMS

Plasma levels of inflammatory markers are increased in chronic heart failure (HF) and are also subclinical indicators of future HF. Inflammation is strictly correlated with clotting activation, but the association between inflammation, hypercoagulability and prognosis in HF has not been previously reported.

METHODS AND RESULTS

Markers of inflammation (interleukin-6; IL-6, and C-reactive protein; CRP) and hypercoagulability (D-dimer; DD, and thrombin-antithrombin III complex; TAT) were prospectively assessed in 214 subjects with New York Heart Association (NYHA) functional class II-IV HF. During a median follow-up of 8.5 months, 32 patients had an event: 13 died and 19 were hospitalized because of worsening of HF. IL-6, DD and TAT levels were all significantly associated with increased risk of death after adjustment for other known HF prognostic factors (age, gender, traditional cardiovascular risk factors, NYHA class, systolic left ventricular function, renal failure, hemoglobin, serum sodium) in a Cox multivariate proportional hazard model (P = 0.003, P = 0.01 and P = 0.02, respectively). When these markers were added simultaneously to the known prognostic factors in a new Cox multivariate model, only DD levels were significant predictors of mortality (hazard ratio [95% confidence interval; CI]: 11 [2.7-45.1], P = 0.001). The Kaplan-Meier curve revealed a significantly better outcome in patients with DD below 450 ng mL(-1). NT-pro-BNP was the only significant predictor of rehospitalization (HR [95% CI]: 5.3 [2.0-13.8], P < 0.001).

CONCLUSION

Hypercoagulability and inflammation, as assessed by DD, TAT and IL-6 levels, are associated with an increased mortality risk in HF.

Authors+Show Affiliations

Department of Heart and Vessels, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Viale Morgagni 85, 50134 Florence, Italy. r.marcucci@dac.unifi.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16689753

Citation

Marcucci, R, et al. "Markers of Hypercoagulability and Inflammation Predict Mortality in Patients With Heart Failure." Journal of Thrombosis and Haemostasis : JTH, vol. 4, no. 5, 2006, pp. 1017-22.
Marcucci R, Gori AM, Giannotti F, et al. Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemost. 2006;4(5):1017-22.
Marcucci, R., Gori, A. M., Giannotti, F., Baldi, M., Verdiani, V., Del Pace, S., Nozzoli, C., & Abbate, R. (2006). Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. Journal of Thrombosis and Haemostasis : JTH, 4(5), 1017-22.
Marcucci R, et al. Markers of Hypercoagulability and Inflammation Predict Mortality in Patients With Heart Failure. J Thromb Haemost. 2006;4(5):1017-22. PubMed PMID: 16689753.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. AU - Marcucci,R, AU - Gori,A M, AU - Giannotti,F, AU - Baldi,M, AU - Verdiani,V, AU - Del Pace,S, AU - Nozzoli,C, AU - Abbate,R, PY - 2006/5/13/pubmed PY - 2006/8/1/medline PY - 2006/5/13/entrez SP - 1017 EP - 22 JF - Journal of thrombosis and haemostasis : JTH JO - J Thromb Haemost VL - 4 IS - 5 N2 - BACKGROUND AND AIMS: Plasma levels of inflammatory markers are increased in chronic heart failure (HF) and are also subclinical indicators of future HF. Inflammation is strictly correlated with clotting activation, but the association between inflammation, hypercoagulability and prognosis in HF has not been previously reported. METHODS AND RESULTS: Markers of inflammation (interleukin-6; IL-6, and C-reactive protein; CRP) and hypercoagulability (D-dimer; DD, and thrombin-antithrombin III complex; TAT) were prospectively assessed in 214 subjects with New York Heart Association (NYHA) functional class II-IV HF. During a median follow-up of 8.5 months, 32 patients had an event: 13 died and 19 were hospitalized because of worsening of HF. IL-6, DD and TAT levels were all significantly associated with increased risk of death after adjustment for other known HF prognostic factors (age, gender, traditional cardiovascular risk factors, NYHA class, systolic left ventricular function, renal failure, hemoglobin, serum sodium) in a Cox multivariate proportional hazard model (P = 0.003, P = 0.01 and P = 0.02, respectively). When these markers were added simultaneously to the known prognostic factors in a new Cox multivariate model, only DD levels were significant predictors of mortality (hazard ratio [95% confidence interval; CI]: 11 [2.7-45.1], P = 0.001). The Kaplan-Meier curve revealed a significantly better outcome in patients with DD below 450 ng mL(-1). NT-pro-BNP was the only significant predictor of rehospitalization (HR [95% CI]: 5.3 [2.0-13.8], P < 0.001). CONCLUSION: Hypercoagulability and inflammation, as assessed by DD, TAT and IL-6 levels, are associated with an increased mortality risk in HF. SN - 1538-7933 UR - https://www.unboundmedicine.com/medline/citation/16689753/Markers_of_hypercoagulability_and_inflammation_predict_mortality_in_patients_with_heart_failure_ L2 - https://doi.org/10.1111/j.1538-7836.2006.01916.x DB - PRIME DP - Unbound Medicine ER -